Primary duodenal T/histiocyte-rich large B-cell lymphoma complicated with obstructive jaundice: A case report and review of literature

Table 1 Clinical characteristics and prognosis of primary gastrointestinal T/histiocyte-rich large B-cell lymphoma

Ref.	Age/sex	Site	Lesion type	Biopsy method	Stage	Treatment	Follow-up
Tóth et al[7], 1997	77/F	Gastric antrum	Ulcerative	Surgery	IE	Partial gastrectomy	18 months/survived
Barut et al[8], 2016	76/F	Stomach	Mixed	Surgery	NA	Surgery + chemotherapy	NR
Zehani et al[9], 2017	41/M	Stomach	Ulcerative	Surgery	NA	Total gastrectomy	4 days/died
Tan et al[10], 2018	NR/M	Gastric corpus	Ulcerative	Surgery	IE	Partial gastrectomy + CHOP	2 years/survived
Sogunro et al[11], 2020	55/M	Gastric fundus	Ulcerative	Surgery	IV	Splenectomy + gastric fundus resection + distal pancreatectomy + R-CHOP	NR
Udhreja et al[12], 2009	55/F	Cecum, ascending colon	Mixed	Surgery	II	Resection of cecum and ascending colon	NR
Agrawal et al[13], 2020	41/M	Ascending colon	Ulcerative	Surgery	II	Right hemicolectomy + R-CHOP	NR
Li et al[14], 2019	48/M	Ileum	Elevated	Surgery	IIE	Right hemicolectomy	NR
Köksal et al[15], 2013	28/M	Duodenum	Mixed	Endoscopy	IE	R-CHOP	1 year/survived

M: Male; F: Female; CHOP: Cyclophosphamide, doxorubicin, vincristine, prednisone; R: Rituximab; NR: Not reported; NA: Not assessable.